Microcirculation alterations in severe COVID-19 pneumonia

Vanina Siham Kanoore Edul1, Juan Francisco Caminos Eguillor2, Gonzalo Ferrara3

  • 1Hospital Juan A Fernández, Ciudad Autónoma de Buenos Aires, Argentina; Cátedra de Farmacología Aplicada, Facultad de Ciencias Médicas, Universidad Nacional de La Plata, La Plata, Argentina; Sanatorio Otamendi, Buenos Aires, Argentina.

Journal of Critical Care
|October 23, 2020
PubMed
Abstract

Insights

COVID-19 pneumonia alters tissue perfusion, with reduced sublingual microvascular flow and velocity. Patients exhibited high vascular densities, potentially due to angiogenesis or hypoxia, indicating significant microcirculatory changes.

Area of Science:

  • Critical Care Medicine
  • Microcirculation Research
  • COVID-19 Pathophysiology

Background:

  • COVID-19 pneumonia can lead to systemic complications, including microcirculatory dysfunction.
  • Assessing tissue perfusion is crucial for managing critically ill patients with COVID-19.

Purpose of the Study:

  • To investigate sublingual microcirculatory and skin perfusion alterations in mechanically ventilated COVID-19 pneumonia patients.
  • To characterize microvascular changes associated with COVID-19 acute respiratory distress syndrome.

Main Methods:

  • Prospective observational study of 27 mechanically ventilated COVID-19 patients.
  • Sublingual microcirculation assessed using hand-held videomicroscopy with software analysis.
  • Capillary refill time measured to evaluate peripheral perfusion.

Main Results:

  • Patients presented with prolonged capillary refill time (3.5s).
  • Sublingual microcirculation showed reduced proportion of perfused vessels (0.96) and lower red blood cell velocity (1124 μm/s).
  • High total and perfused vascular densities (21.9 mm/mm² and 21.0 mm/mm²) were observed, with an inverse correlation between perfused vessels and total vascular density.

Conclusions:

  • COVID-19 pneumonia is associated with significant alterations in tissue perfusion and sublingual microcirculation.
  • Observed microcirculatory changes include decreased vessel perfusion and flow velocity, alongside increased vascular density.
  • Elevated vascular density may indicate compensatory angiogenesis or hypoxia-driven capillary recruitment in response to COVID-19.

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
831
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.9K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.1K
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
395
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.6K